Insiders · FNCH

Lance E Thibault

Officer at Finch Therapeutics Group, Inc. (FNCH) since May 2023

Lance E Thibault has filed 2 insider reports with the SEC since September 2021, as officer at Finch Therapeutics Group, Inc. (FNCH) and officer at Aadi Bioscience, Inc. (WHWK). The latest filing, on May 16, 2023, is a Form 3: Lance E Thibault became an insider at Finch Therapeutics Group, Inc. (FNCH).

Filings
2
Companies
2
Bought on market
None
Sold on market
None

Companies where Lance E Thibault is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Finch Therapeutics Group, Inc. logo
FNCH
Finch Therapeutics Group, Inc.
Officersince May 2023May 16, 2023
Aadi Bioscience, Inc. logo
WHWK
Aadi Bioscience, Inc.
Officersince August 2021$3.13Sep 1, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Lance E Thibault with

Other insiders at the same companies

Questions about Lance E Thibault

What is Lance E Thibault's role at Finch Therapeutics Group, Inc.?
Lance E Thibault reports to the SEC as officer at Finch Therapeutics Group, Inc. (FNCH), according to the latest filing on May 16, 2023. Lance E Thibault has also filed as officer at Aadi Bioscience, Inc. (WHWK).
Has Lance E Thibault bought or sold stock recently?
No open-market purchases or sales by Lance E Thibault are on file.
How do I get alerts when Lance E Thibault files?
Follow Lance E Thibault on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Lance E Thibault (SEC CIK 0001158485). Totals count each trade once, skipping amendments whose original is on file, from Sep 1, 2021 on. View on SEC EDGAR